Phase I Study of the Combination of Anlotinib With Gefitinib

NCT03602027 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Non-squamous Non-small Cell Lung Cancer

Interventions

DRUG: Anlotinib
DRUG: Gefitinib

Sponsor

Second Affiliated Hospital of Nanchang University